Stockreport

Inovio Pharmaceuticals Inc (INO) Q4 2025 Earnings Call Highlights: Strategic Moves and ... [Yahoo! Finance]

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF This article first appeared on GuruFocus Cash, Cash Equivalents, and Short-term Investments: $58.5 million as of December 31, 2025. Operating Expenses (Q4 2025): $1 [Read more]